• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Radiol . Dynamic evaluation of lung involvement during coronavirus disease-2019 (COVID-19) with quantitative lung CT

tetano

Editor, Senior Moderator
Emerg Radiol


. 2020 Oct 10.
doi: 10.1007/s10140-020-01856-4. Online ahead of print.
Dynamic evaluation of lung involvement during coronavirus disease-2019 (COVID-19) with quantitative lung CT


Chun Ma[SUP] 1 [/SUP], Xiao-Ling Wang[SUP] 1 [/SUP], Dong-Mei Xie[SUP] 1 [/SUP], Yu-Dan Li[SUP] 1 [/SUP], Yong-Ji Zheng[SUP] 1 [/SUP], Hai-Bing Zhang[SUP] 1 [/SUP], Bing Ming[SUP] 2 [/SUP]



Affiliations

Abstract

Purpose: To identify and quantify lung changes associated with coronavirus disease-2019 (COVID-19) with quantitative lung CT during the disease.
Methods: This retrospective study reviewed COVID-19 patients who underwent multiple chest CT scans during their disease course. Quantitative lung CT was used to determine the nature and volume of lung involvement. A semi-quantitative scoring system was also used to evaluate lung lesions.
Results: This study included eighteen cases (4 cases in mild type, 10 cases in moderate type, 4 cases in severe type, and without critical type cases) with confirmed COVID-19. Patients had a mean hospitalized period of 24.1 ? 7.1 days (range: 14-38 days) and underwent an average CT scans of 3.9 ? 1.6 (range: 2-8). The total volumes of lung abnormalities reached a peak of 8.8 ? 4.1 days (range: 2-14 days). The ground-glass opacity (GGO) volume percentage was higher than the consolidative opacity (CO) volume percentage on the first CT examination (Z = 2.229, P = 0.026), and there was no significant difference between the GGO volume percentage and that of CO at the peak stage (Z = - 0.628, P = 0.53). The volume percentage of lung involvement identified by AI demonstrated a strong correlation with the total CT scores at each stage (r = 0.873, P = 0.0001).
Conclusions: Quantitative lung CT can automatically identify the nature of lung involvement and quantify the dynamic changes of lung lesions on CT during COVID-19. For patients who recovered from COVID-19, GGO was the predominant imaging feature on the initial CT scan, while GGO and CO were the main appearances at peak stage.

Keywords: Artificial intelligence; Coronavirus; Lung; Pneumonia; Tomography; X-ray; viral.
 
Back
Top Bottom